Skip to main content

Table 3 Statistical differences between treatments at time point 3d (day 3)

From: Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

Cell lineVemurafenib vs controlPLX4720 vs controlSorafenib vs control
MEL-2805P = 0.093P = 0.384P = 0.343
MEL-2492P = 0.044P = 0.050P = 0.927
MEL-3025P = 0.003P = 0.010P = 0.290
MEL-2523P = 0.087P = 0.220P = 0.369
MEL-3104P = 0.069P = 0.067P = 0.938
  1. Statistically significant P-values are in italics (P ≤ 0.05)
  2. P-values were obtained by two-tailed paired Student’s t-test